Navigation Links
New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures
Date:10/30/2007

rsh III. Image quality was sufficient to allow evaluation of morphological characteristics in 93% of sites; resolution was sufficient in 91%. Epithelial width could be measured in 94% and villous width in 88%. Epithelial cell cytoplasm and basal cell layer regularity could only be assessed in 30% and 26%, respectively. Investigators conclude that Cellvizio(R) GI can identify histological details critical for the detection of hallmark features of intestinal pathology in celiac patients.

Physicians from Klinikum rechts der Isar in Munich, Germany presented results from a preclinical study that investigated the optimal timing for use of Cellvizio(R) GI imaging with intravenous fluorescein in a pig model in a poster (Abstract PS-W-22). Results demonstrate that fluorescein-enhanced imaging of the gastrointestinal tract with Cellvizio(R) delivers best contrast and image quality one to eight minutes after fluorescein injection, with best resolution after five minutes. The authors conclude that these data may facilitate development of standardized protocols for utilizing Cellvizio(R) GI in clinical practice. Standard protocols are expected to facilitate more widespread adoption and appropriate application of this innovative imaging technology.

About Mauna Kea Technologies:

Mauna Kea Technologies engages in the conception, development, fabrication and commercialization of novel high-speed minimally invasive imaging systems for in-vivo and in-situ microscopy. MKT's unique fiber-based microscopy platform, Cellvizio(R), is the world's smallest microscope with multifarious applications in research and medicine. MKT's products, developed at the crossroads of optics, mathematics, image processing, biology and medicine, currently address the markets of digestive endoscopy, bronchoscopy and small animal imaging. For more information, visit http://www.maunakeatech.com.

For further information:

Fern
'/>"/>

SOURCE Mauna Kea Technologies
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 /PRNewswire/ ... blood glucose device is a home-based electronic device. ... transmitter that transmits information about glucose levels through ... it is displayed. The regular usage of self-monitoring ... and prompt an individual to undergo proper diabetes ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
Breaking Medicine Technology:Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... device to identify the, lipid core (fatty) coronary plaques ... ... Mass., May 15 InfraReDx, Inc. today,announced that physicians at ... Coronary Imaging System in a patient,undergoing a cardiac catheterization. This ...
... BONITA SPRINGS, Fla., May 15 Tigris Pharmaceuticals,Inc. ... and,Development Agreement (CRADA) with the National Cancer Institute ... AFP-464, an,aminoflavone currently in Phase I development. AFP-464 ... resulting in p53 activation and,apoptosis., This is ...
Cached Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3
(Date:9/3/2015)... ... 2015 , ... BedJet released a new version of its award winning personal ... the BedJet v2 pre-order campaign blazed past the $1 million dollar mark ... on crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the award winning ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... ... 03, 2015 , ... Hope For The Warriors® is pleased ... are awarded two times each year to spouses or caregivers of post-9/11 wounded ... to restoring a sense of self, restoring the family unit, and restoring hope ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
Breaking Medicine News(10 mins):Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... that may put people with schizophrenia at risk for ... in altered brain activity in schizophrenia is not clear. ... at the University of Pennsylvania have come together using ... unique high-speed imaging technique - to understand how schizophrenia ...
... , THURSDAY, Oct. 13 (HealthDay News) -- Human children are ... a new study finds. Researchers compared the responses of ... Republic of Congo sanctuary. Both the children and the ... own or with a partner. Individuals could pull two ends ...
... Reporter , THURSDAY, Oct. 13 (HealthDay News) -- The symptoms ... come on weekdays, specifically when your child should be heading ... and it can take different forms in many age groups. ... school avoidance "remains a serious problem," said Alan Hilfer, director ...
... This press release is available in Spanish ... Department of Agriculture (USDA) and published recently in the journal ... new varieties of broccoli have not declined since 1975, and ... iron, magnesium, potassium and other minerals that have made the ...
... the International Osteoporosis Foundation (IOF) is releasing a 24-page ... strong muscles. Professor Heike Bischoff-Ferrari, director Centre ... City Hospital and author of the report, stated, "Put ... optimize your bone health by following three essential steps." ...
... exposed to tobacco smoke for a period of months, researchers ... disease (COPD) develops. In the October 14th issue of ... a promising new way to reverse the lung damage underlying ... clear what causes the disease and there has been no ...
Cached Medicine News:Health News:Penn team links schizophrenia genetics to disruption in how brain processes sound 2Health News:Young Children Collaborate Better Than Chimps 2Health News:Why Johnny Won't Go to School 2Health News:Why Johnny Won't Go to School 3Health News:USDA research demonstrates new breeds of broccoli remain packed with health benefits 2Health News:Three steps to unbreakable bones on World Osteoporosis Day 2Health News:Reversing smoke-induced damage and disease in the lung 2
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... Location-ID™ product solutions were developed to assist ... assets. To maximize use of existing capital ... increase the productivity of their employees, organizations ... track their valuable assets and ensure those ...
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Medicine Products: